Health
Oxford/AstraZeneca vaccine: rare blood clot syndrome has high mortality rate – The Guardian
Researchers found that clots occurring after first dose of Oxford jab affected otherwise young and healthy people
CoronavirusResearchers found that clots occurring after first dose of Oxford jab affected otherwise young and healthy people
Although extremely rare, a blood clot syndrome after the first dose of the Oxford/AstraZeneca vaccine carries a high risk of death…
Continue Reading
-
General17 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News17 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General19 hours agoPerth man charged after investigation into organised crime and tobacco store attacks
-
General24 hours agoCrowe toasts talkback titan for platforming ‘voiceless’